Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
252.00    -1.80 (-0.71%)
Bid:
252.20
Ask:
252.80
Spread: 0.60 (0.238%)
Market Cap: £635.01m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Director/PDMR Shareholding

7 May 2021 17:00

RNS Number : 9864X
Genuit Group PLC
07 May 2021
 

Genuit Group plc (the "Company")

Notification of transactions by Person Discharging Managerial Responsibilities

The Company announces that on 4 May 2021, Martin Payne, Chief Executive Officer and a Person Discharging Managerial Responsibilities, exercised the following options:

1. a nil-cost option over a total of 8,036 shares (comprising 7,738 shares granted under the Award and 298 shares awarded at vesting in lieu of dividends paid during the vesting period) in accordance with the Deferred Share Bonus Plan Award granted to him on 2 May 2018. Mr. Payne sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

 

2. a nil-cost option over a total of 8,094 shares (comprising 7,871 shares granted under the Award and 223 shares awarded at vesting in lieu of dividends paid during the vesting period) in accordance with the Deferred Share Bonus Plan Award granted to him on 30 April 2019. Mr. Payne sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

Mr. Payne now holds an interest in a total of 265,481 shares.

The notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Martin Payne

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Genuit Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

b)

 

Nature of the transaction

 

 

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options as follows:

Deferred Share Bonus Plan ("DSBP") award granted on 2 May 2018.

Deferred Share Bonus Plan ("DSBP") award granted on 30 April 2019.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

4,276 - Number of DSBP shares acquired from 2 May 2018 grant after reduction for appropriate tax and national insurance liabilities.

 

4,308 - Number of DSBP shares acquired from 30 April 2019 grant after reduction for appropriate tax and national insurance liabilities.

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

6 May 2021

f)

 

Place of the transaction

 

 

Outside a Trading Venue

 

Enquiries:

Emma Versluys, Company Secretary

+44 (0) 1709 770 000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKOBPPBKDAPK
Date   Source Headline
2nd Jun 20261:15 pmRNSDirector/PDMR Shareholding
29th May 20262:39 pmRNSTotal Voting Rights
29th May 20262:23 pmRNSHolding(s) in Company
29th May 20261:59 pmRNSDirector/PDMR Shareholding
28th May 20262:24 pmRNSHolding(s) in Company
27th May 202610:07 amRNSDirector/PDMR Shareholding
26th May 20263:49 pmRNSHolding(s) in Company
22nd May 20263:01 pmRNSResult of AGM
22nd May 20267:00 amRNSTrading Update
5th May 20269:00 amRNSDirector/PDMR Shareholding
1st May 20264:12 pmRNSDirector/PDMR Shareholding
30th Apr 20264:26 pmRNSAdmission to Trading
30th Apr 20264:17 pmRNSTotal Voting Rights
30th Apr 20264:06 pmRNSDirector/PDMR Shareholding
27th Apr 20264:20 pmRNSHolding(s) in Company
14th Apr 20264:32 pmRNSDirector/PDMR Shareholding
14th Apr 202610:11 amRNSNotice of AGM
10th Apr 20261:34 pmRNSBlock Listing Application
7th Apr 20269:58 amRNSHolding(s) in Company
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20266:01 pmRNSTotal Voting Rights
23rd Mar 20263:25 pmRNSHolding(s) in Company
20th Mar 20261:43 pmRNSDirector/PDMR Shareholding
13th Mar 20269:41 amRNSHolding(s) in Company
13th Mar 20269:41 amRNSHolding(s) in Company
11th Mar 20262:12 pmRNSFull-Year 2025 Results Investor Q&A
10th Mar 20267:00 amRNSFinal Results
6th Mar 202611:35 amRNSHolding(s) in Company
5th Mar 20262:46 pmRNSHolding(s) in Company
5th Mar 20262:41 pmRNSHolding(s) in Company
4th Mar 20262:40 pmRNSHolding(s) in Company
3rd Mar 20263:51 pmRNSHolding(s) in Company
2nd Mar 20265:25 pmRNSHolding(s) in Company
27th Feb 20263:18 pmRNSTotal Voting Rights
30th Jan 20266:00 pmRNSTotal Voting Rights
29th Jan 202610:17 amRNSHolding(s) in Company
29th Jan 202610:15 amRNSHolding(s) in Company
29th Jan 202610:06 amRNSHolding(s) in Company
12th Jan 20265:41 pmRNSHolding(s) in Company
31st Dec 202510:00 amRNSTotal Voting Rights
31st Dec 202510:00 amRNSTotal Voting Rights
23rd Dec 20259:08 amRNSHolding(s) in Company
23rd Dec 20259:08 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
16th Dec 20252:03 pmRNSHolding(s) in Company
16th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20253:41 pmRNSDirector/PDMR Shareholding
10th Dec 20254:11 pmRNSDirector/PDMR Shareholding
9th Dec 202510:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.